Intrauterine release of progesterone antagonist ZK230211 is feasible and results in novel endometrial effects: A pilot study

Human Reproduction

Volumn 22, Issue 9, 2007, Pages 2515-2522

  Heikinheimo, Oskari ^a   Vani, Susheel ^b   Carpén, Olli ^c   Tapper, Annamaija ^a   Härkki, Päivi ^a   Rutanen, Eeva Marja ^a   Critchley, Hilary ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

Endometrium; Insulin like growth factor binding protein 1; Levonorgestrel; Progesterone antagonist; ZK230211

Indexed keywords

11BETA (4 ACETYLPHENYL) 17BETA HYDROXY 17ALPHA (1,1,2,2,2 PENTAFLUOROETHYL)ESTRA 4,9 DIEN 3 ONE; ANDROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HISTONE H3; KI 67 ANTIGEN; LEVONORGESTREL; PROGESTERONE RECEPTOR; SOMATOMEDIN BINDING PROTEIN 1;

ADULT; AMENORRHEA; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED STUDY; DYSMENORRHEA; ENDOMETRIUM; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; INTRAUTERINE CONTRACEPTIVE DEVICE; MENORRHAGIA; MENSTRUAL CYCLE; PROGESTERONE RELEASE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; UTERINE BLEEDING PATTERN;

EID: 34548072476     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dem235     Document Type: Article

References (36)

1. Andersson K, Odlind V, Rybo G. Levonorgestrel and copper-releasing IUDs during five years of use: A randomized comparative trial. Contraception 1994;49:56-72.
2. Baird D, Brown A, Critchley H, Williams A, Lin S, Cheng L. Effect of long-term treatment with low-dose mifepristone on the endometrium. Hum Reprod 2003:18:61-68.
3. Bell SC, Jackson JA, Ashmore J, Zhu HH, Tseng L. Regulation of insulin-like growth factor-binding protein-1 synthesis and secretion by progestin and relaxin in long term cultures of human endometrial stromal cells. J Clin Endocrinol Metab 1991;72:1014-1024.
4. Brenner R, Slayden O. Flutamide counteracts the antiproliferative effects of antiprogestins in the primate endometrium. J Clin Endocrinol Metab 2003;88:946-949.
5. Brenner B, Slayden O. Progesterone receptor antagonists and the endometrial antiproliferative effect. Semin Reprod Med 2005;23 74-81.
6. Brenner R, Slayden O, Rodgers W, Critchley H, Carroll R, Jing Nie X, Mah K. Immunohistochemical assessment of mitotic activity with an antibody to phosphorylated histone H3 in the macaque and human endometrium. Hum Reprod 2003;18:1185-1193.
7. Burton K, Henderson T, Hillier S, Mason I, Habib F, Brenner R, Critchley H. Local levonorgestrel regulation of androgen receptor and 17β-hydroxysteroid dehydrogenase type 2 expression in human endometrium. Hum Reprod 2003;18:2610-2617.
8. Chwalisz K, Brenner R, Fuhrmann U, Hess-Stumpp H, Elger W. Antiproliferative effects of progesterone antagonists and progesterone receptor modulators on the endometrium. Steroids 2000;65 741-751.
9. Chwalisz K, Perez M, DeManno D, Winkel C, Schubert G, Elger W. Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis. Endocr Rev 2005;26:423-438.
10. Critchley H, Wang H, Jones R, Kelly R, Drudy T, Gebbie A, Buckley C, McNeilly A, Glasier A. Morphological and functional features of endometrial decidualization following long-term intrauterine levonorgestrel delivery. Hum Reprod 1998a;13:1218-1224.
11. Critchley H, Wang H, Kelly R, Gebbie A, Glasier A. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system. Hum Reprod 1998b;13:1210-1217.
12. Critchley H, Brenner R, Henderson T, Williams K, Nayak N, Layden O, Millar M, Saunders P. Estrogen receptor β, but not estrogen receptor α, is present in the vascular endothelium of the human and nonhuman primate endometrium. J Clin Endocrinol Metab 2001;86 1370-1378.
13. Dugoff L, Jones OW, III, Allen-Davis J, Hurst BS, Schlaff WD. Assessing the acceptability of Norplant contraceptive in four patient populations. Contraception 1995;52:45-49.
14. Fuhrmann U, Hess-Stumpp H, Cleve A, Neef G, Schwede W, Hoffmann J, Fritzemeier KH, Chwalisz K. Synthesis and biological activity of a novel, highly potent progesterone receptor antagonist. J Med Chem 2000;43:5010-5016.
15. Gao JG, Mazalla J, Tseng L. Activation of the human IGFBP-1 gene promoter by progestin and relaxin in primary culture of human endometrial stromal cells. Mol Cell Endocrinol 1994;104 39-46.
16. Heikinheimo O, Gordon K, Lähteenmäki P, Williams R, Hodgen G. Antiovulatory actions of RU486 - the pituitary is not the primary site of antiprogestin action in vivo. J Clin Endocrinol Metab 1995; 80: 1859-1868.
17. Heikinheimo O, Hsiu JG, Gordon K, Kim S, Williams R, Gibbons W, Hodgen G. Endometrial effects of RU486 - antiproliferative effects despite signs of estrogen action and increased cyclin-B expression. J Steroid Biochem Mol Biol 1996;59:179-190.
18. Henderson T, Saunders P, Moffett-King A, Groome N, Critchley H. Steroid receptor expression in uterine natural killer cells. J Clin Endocrinol Metab 2003;88:440-449.
19. Hurskainen R, Salmi A, Paavonen J, Teperi J, Rutanen EM. Expression of sex steroid receptors and Ki-67 in the endometria of menorrhagic women: effects of intrauterine levonorgestrel. Mol Hum Reprod 2000;6 1013-1018.
20. Hurskainen R, Teperi J, Rissanen P, Aalto AM, Grenman S, Kivelä A, Kujansuu E, Vuorma S, Yliskoski M, Paavonen J. Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: Randomized trial 5-year follow-up. JAMA 2004;291:1456-1463.
21. Kovacs G. Progestogen-only pills and bleeding disturbances. Hum Reprod 1996;11(Suppl 2):20-23.
22. Luukkainen T, Toivonen J. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties. Contraception 1995; 52:269-276.
23. Narvekar N, Cameron S, Critchcley H, Lin S, Cheng L, Baird D. Low-dose mifepristone inhibits endometrial proliferation and up-regulates androgen receptor. J Clin Endocrinol Metab 2004;89:2491-2497.
24. Nayak NR, Slayden OD, Chwalisz K, Lehtinen M, Brenner RM. Antiprogestin-releasing intrauterine devices: A novel approach to endometrial contraception. American Society for Reproductive Medicine, Fifty-sixth Annual Meeting, San Diego, CA, USA, 2000. Abstract O-187.
25. Pekonen F, Nyman T, Lähteenmäki P, Haukkamaa M, Rutanen EM. Intrauterine progestin induces continuous insulin-like growth factor-binding protein-1 production in the human endometrium. J Clin Endocrinol Metab 1992;75:660-664.
26. Phillips V, Gratham CT, Manek S, McCluggage WG. The effects of the levonorgestrel intrauterine system (Mirena coil) on endometrial morphology. J Clin Pathol 2003;56:305-307.
27. Rutanen E-M, Koistinen R, Wahlström T, Sjöberg J, Stenman U-H, Seppälä M. Placental protein 12 (PP12) in the human endometrium: tissue concentration in relation to histology and serum levels of PP12, progesterone and oestradiol. Br J Obstet Gynaecol 1984a;91 377-381.
28. Rutanen E-M, Koistinen R, Wahlström T, Bohn H, Seppälä M. The content of placental protein 12 in decidua and fetal membranes is greater than in placenta. Brit J Obstet Gynaecol 1984b;91 1240-1244.
29. Rutanen E-M, Salmi A, Nyman T. mRNA expression of insulin-like growth factor-I (IGF-I) is suppressed and those of IGF-II and IGF-binding protein-1 are constantly expressed in the endometrium during use of an intrauterine levonorgestrel system. Mol Hum Reprod 1997;3 749-754.
30. Silverberg SG, Haukkamaa M, Arko H, Nilsson CG, Luukkainen T. Endometrial morphology during long term use of levonorgestrel-releasing intrauterine devices. Int J Gynecol Pathol 1986;15:235-241.
31. Slayden O, Brenner B. RU486 action after estrogen priming in the endometrium and oviducts of rhesus monkeys (Macaca mulatta). J Clin Endocrinol Metab 1994;78:440-448.
32. Slayden O, Hirst J, Brenner B. Estrogen action in the reproductive tract during antiprogestin treatment. Endocrinology 1993;132 1845-1856.
33. Slayden O, Zelinski-Wooten M, Chwalisz K, Stouffer R, Brenner R. Chronic treatment of cycling rhesus monkeys with low doses of antiprogestin ZK 137 316: Morphometric assessment of the uterus and oviduct. Hum Reprod 1998;13:269-277.
34. Slayden O, Chwalisz K, Brenner B. Reversible suppression of menstruation with progesterone antagonists in rhesus macaques. Hum Reprod 2001; 16:1562-1574.
35. Williams A, Critchley H, Osei J, Ingamells S, Cameron I, Han C, Chwalisz C. The effects of the selective progesterone receptor modulator asoprisnil on the morphology of uterine tissues after 3 months of treatment in patients with symptomatic uterine leiomyoma. Hum Reprod 2007;22:1696-1704.
36. Wolf J, Hsiu J, Anderson T, Ulmann A, Baulieu E, Hodgen G. Noncompetitive antiestrogenic effect of RU 486 in blocking the estrogen-stimulated luteinizing hormone surge and the proliferative action of estradiol on endometrium in castrate monkeys. Fertil Steril 1989;52:1055-1060.